Antibiotics

>

Latest News

CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas
CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas

December 20th 2024

Jason M Pogue, PharmD, BCPS, BCIDP discusses the findings, pharmacokinetics, why ceftolozane-tazobactam may be the preferred choice for resistant infections, and more.

Argument Against Antibiotics for Strep Throat in Children
Argument Against Antibiotics for Strep Throat in Children

November 11th 2024

What's New In 2024: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
What's New In 2024: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

November 4th 2024

Antimicrobial Resistance: A Catastrophic (and Neglected) Biological Threat
Antimicrobial Resistance: A Catastrophic (and Neglected) Biological Threat

October 30th 2024

Antibiotic Course for Bloodstream Infections Can Safely Be Reduced by Half the Time
Antibiotic Course for Bloodstream Infections Can Safely Be Reduced by Half the Time

October 18th 2024

© 2024 MJH Life Sciences

All rights reserved.